13F

Stock

Neurocrine Biosciences Inc

NBIX · held by 5 managers

Reported value

$26.3M

Holders

5

+1 new · −0 exited

Holders’ est. mark

$473.9K

Price effect on 2 books still in the name

Largest holder

$19.7M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC840.8K$19.7MHeld
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main52.1K$6.23M$465.7KAdded$2.49M
Swiss Life Asset Management Ltd2.52K$300.5KNew
Leonteq Securities AG619$73.9K$8.19KCut−$138.6K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.